rps3 Antibody

What is RPS3 and why is it significant in research?

RPS3 (Ribosomal Protein S3) is a multifunctional protein that serves as a component of the 40S small ribosomal subunit. Beyond its canonical role in protein synthesis, RPS3 performs various extra-ribosomal functions, most notably DNA repair endonuclease activity. It possesses the ability to cleave phosphodiester bonds in DNAs containing altered bases and displays high binding affinity for DNA lesions caused by reactive oxygen species (ROS), particularly 7,8-dihydro-8-oxoguanine (8-oxoG) . RPS3 also stimulates the N-glycosylase activity of base excision protein OGG1 and enhances the uracil excision activity of UNG1 .

Recent studies have identified RPS3 as a protein secreted from cancer cells, suggesting its potential utility as a cancer biomarker . Additionally, RPS3 has been implicated in cellular signaling pathways, including JAK/STAT and oxidative stress signaling . These diverse functions make RPS3 an important target for research across multiple fields, including cancer biology, DNA repair mechanisms, and cellular stress responses.

What types of RPS3 antibodies are available for research applications?

Research laboratories can access several types of RPS3 antibodies, each with distinct characteristics:

Polyclonal Antibodies:

• Rabbit polyclonal antibodies targeting various epitopes of RPS3

• Recognize multiple epitopes on the RPS3 protein

• Applications typically include WB, IHC, IF, ELISA

Monoclonal Antibodies:

• Rabbit monoclonal antibodies such as EPR7807

• Mouse monoclonal antibodies (e.g., clone 2A8, RP159-1)

• Target specific epitopes with high specificity

• Offer improved batch-to-batch consistency

Region-Specific Antibodies:

• Antibodies targeting specific amino acid regions, such as:

  • AA 171-220

  • AA 200 to C-terminus

  • AA 144-243

  • AA 101-200

  • C-terminal region

The choice between these antibody types depends on the specific research application, with monoclonal antibodies generally preferred for experiments requiring high specificity and reproducibility, while polyclonal antibodies may offer advantages in detecting proteins present at low concentrations due to their ability to recognize multiple epitopes.

What are the common research applications for RPS3 antibodies?

RPS3 antibodies are versatile tools used across multiple experimental techniques:

When selecting an application, researchers should consider the specific experimental context and validate the antibody's performance in their particular system.

How is epitope mapping performed for RPS3 antibodies, and why is it important?

Epitope mapping is crucial for characterizing antibody specificity and understanding antibody-antigen interactions. For RPS3 antibodies, researchers have employed peptide scanning techniques to identify specific binding regions.

In a comprehensive study by Kim et al., polyclonal (pAb) and monoclonal antibodies (mAbs) against RPS3 were characterized through epitope mapping . Their methodology involved:

• Systematic scanning of amino acid residues from position 185 to 243 of RPS3

• Synthesis of overlapping peptides spanning this region

• Assessment of antibody binding to these peptides to identify specific epitope regions

Their results demonstrated distinct epitope specificities:

• Polyclonal antibody R2: epitope from amino acid 203 to 230

• Monoclonal antibody M7: epitope from amino acid 213 to 221

• Monoclonal antibody M8: epitope from amino acid 197 to 219

Understanding these epitope regions is critical for:

• Selecting appropriate antibodies for specific experiments

• Avoiding cross-reactivity with similar proteins

• Designing blocking peptides for specificity controls

• Interpreting experimental results correctly, particularly when different antibodies yield variable results

Researchers should consider epitope information when selecting RPS3 antibodies, especially for experiments where specific domains or post-translational modifications are being studied.

What experimental considerations are important when studying extra-ribosomal functions of RPS3?

When investigating the non-canonical functions of RPS3, researchers should consider several critical experimental factors:

Distinguishing Ribosomal vs. Extra-ribosomal Pools:

• Subcellular fractionation to separate cytoplasmic, nuclear, and ribosome-associated populations

• Use of appropriate controls to distinguish RPS3's direct effects from indirect effects due to altered translation

Studying DNA Repair Functions:

• Design experiments with DNA damage-inducing agents (ROS generators, UV radiation)

• Assess RPS3's endonuclease activity using supercoiled DNA substrates, as RPS3 cleaves supercoiled DNA more efficiently than relaxed DNA

• Use 8-oxoG-containing DNA substrates to leverage RPS3's high binding affinity for this common lesion

Cancer Research Applications:

• Consider both intracellular and secreted forms of RPS3

• Use highly specific antibodies for detecting extracellular RPS3 in biological fluids

• Validate findings with multiple antibodies targeting different epitopes

Signaling Pathway Investigations:

• Recent RNA-seq data shows RPS3+/− cells upregulate JAK/STAT targets Socs36E and chinmo

• Consider JNK pathway interactions, as inhibiting JNK signaling affects RPS3-related gene expression

• Include appropriate controls when manipulating these pathways (e.g., Puc overexpression as a JNK inhibitor)

These experimental designs help isolate and accurately characterize the diverse functions of RPS3 beyond protein synthesis.

How can researchers validate the specificity of RPS3 antibodies in their experimental systems?

Thorough validation is essential to ensure experimental results with RPS3 antibodies are reliable and reproducible. Consider implementing these validation strategies:

Positive and Negative Controls:

• Positive controls: Use cell lines known to express RPS3 (HEK-293, HeLa, MCF-7, NIH/3T3, PC-12)

• Negative controls: RPS3 knockdown/knockout samples, ideally generated using siRNA or CRISPR-Cas9

• Secondary antibody-only controls to assess non-specific binding

Multiple Antibody Validation:

• Compare results using antibodies targeting different epitopes of RPS3

• Confirm findings with both monoclonal and polyclonal antibodies when possible

• Validate commercial antibody performance with published literature

Blocking Peptide Competition:

• Pre-incubate antibody with immunizing peptide (when available)

• Observe signal reduction/elimination in presence of specific blocking peptide

• Use unrelated peptides as negative controls

Western Blot Analysis:

• Confirm detection of a band at the expected molecular weight (approximately 27-33 kDa)

• Assess migration pattern in different sample types

• Consider running gradient gels to better resolve RPS3 from proteins of similar molecular weight

Immunoprecipitation-Mass Spectrometry:

• Perform IP followed by mass spectrometry to confirm antibody pulls down authentic RPS3

• Analyze any co-precipitating proteins for known RPS3 interactors

What are the optimal conditions for using RPS3 antibodies in Western blotting applications?

Successful Western blot analysis with RPS3 antibodies requires careful optimization of several parameters:

Sample Preparation:

• Lyse cells in buffer containing protease inhibitors to prevent degradation of RPS3

• Both RIPA and NP-40 based buffers have been successfully used

• Include phosphatase inhibitors if studying post-translational modifications

Protein Loading and Transfer:

• Recommended loading: 10-30 μg of total protein per lane

• Transfer conditions: Semi-dry or wet transfer at 100V for 60-90 minutes

• Use PVDF membranes for optimal protein retention and antibody binding

Antibody Dilution and Incubation:

• Primary antibody dilutions range from 1:1000 to 1:6000 depending on specific antibody

• Optimal dilution may vary between antibody lots and should be titrated

• Incubation conditions: typically overnight at 4°C or 1-2 hours at room temperature

Detection and Expected Results:

• Expected band size: approximately 27-33 kDa (predicted MW 27 kDa)

• Some antibodies may detect additional bands due to post-translational modifications or splice variants

• Secondary antibody should match host species (typically anti-rabbit or anti-mouse HRP conjugates)

Troubleshooting Common Issues:

• Weak signal: Increase antibody concentration, extend incubation time, or use enhanced chemiluminescence substrate

• High background: Increase blocking time, use more stringent washing, or reduce antibody concentration

• Multiple bands: Optimize sample preparation, consider using more specific monoclonal antibodies

For successful Western blot detection of RPS3, researchers should optimize these conditions for their specific experimental system and antibody.

What are the best practices for immunohistochemistry and immunofluorescence with RPS3 antibodies?

Obtaining reliable and specific staining with RPS3 antibodies in IHC and IF applications requires careful attention to experimental details:

Tissue Preparation and Fixation:

• Formalin-fixed paraffin-embedded (FFPE) sections require proper antigen retrieval

• Recommended antigen retrieval methods: TE buffer pH 9.0 or citrate buffer pH 6.0

• For frozen sections, acetone or methanol fixation may be suitable

Antibody Dilution Ranges:

• IHC applications: 1:100-1:2000 dilution range

• IF applications: 1:50-1:800 dilution range

• Titration experiments are recommended to determine optimal concentration

Blocking and Antibody Incubation:

• Block with 5-10% normal serum from the species of the secondary antibody

• Include 0.1-0.3% Triton X-100 for improved antibody penetration in IF

• Primary antibody incubation: Overnight at 4°C or 1-2 hours at room temperature

• Secondary antibody: 1 hour at room temperature with appropriate species-specific conjugate

Signal Detection and Imaging:

• For IF, mounting media with DAPI for nuclear counterstaining

• For IHC, DAB or other chromogens followed by hematoxylin counterstaining

• Expected localization: Primarily cytoplasmic (ribosomes) with possible nuclear staining (extra-ribosomal functions)

Controls and Validation:

• Include positive control tissues (e.g., liver, testis)

• Primary antibody omission controls

• Isotype controls at matching concentration

• Peptide competition controls where applicable

Researchers should validate staining patterns by comparing results with published literature and consider dual staining with markers of cellular compartments to confirm localization patterns.

How should RPS3 antibodies be stored and handled to maintain optimal activity?

Proper storage and handling of RPS3 antibodies is crucial for maintaining their activity and ensuring reliable experimental results:

Storage Conditions:

• Store at -20°C for long-term storage (up to 1 year from receipt)

• Avoid repeated freeze-thaw cycles which can degrade antibodies

• For antibodies stored in glycerol (typically 40-50% glycerol), aliquoting may be unnecessary for -20°C storage

Working Stock Preparation:

• Prepare small working aliquots to avoid repeated freezing and thawing

• For antibodies without carrier proteins, consider adding BSA (0.1-1%) to improve stability

• Keep on ice when in use during experiments

Buffer Considerations:

• Most RPS3 antibodies are supplied in PBS with additives such as:

  • 50% Glycerol

  • 0.02-0.05% Sodium azide

  • 0.1-0.5% BSA

• These components help maintain antibody stability and prevent microbial growth

Handling Precautions:

• Minimize exposure to light, especially for conjugated antibodies

• Avoid contamination by using clean pipette tips

• Centrifuge briefly before opening vials to collect liquid at the bottom

Stability Indicators:

• Monitor for visible precipitates which may indicate antibody denaturation

• Increased background staining in applications may suggest antibody degradation

• Consider including positive controls with each experiment to monitor antibody performance over time

Following these storage and handling recommendations will help ensure consistent antibody performance across experiments and maximize the useful lifespan of RPS3 antibodies.

What considerations are important when selecting between monoclonal and polyclonal RPS3 antibodies?

The choice between monoclonal and polyclonal RPS3 antibodies should be guided by specific experimental requirements:

Application-Specific Recommendations:

• For detecting specific post-translational modifications: Use monoclonal antibodies targeting the region of interest

• For Western blotting of denatured proteins: Polyclonal antibodies often perform well

• For quantitative applications requiring reproducibility: Recombinant monoclonals offer high consistency

• For immunoprecipitation: Consider epitope accessibility in the native protein conformation

• For challenging applications: Test both types to determine optimal performance

When studying RPS3's extra-ribosomal functions or specific protein interactions, the epitope location becomes particularly important. Researchers should review the available epitope mapping data and select antibodies recognizing regions relevant to the specific function under investigation.